DK490486D0 - COMPOSITION FOR TREATMENT OF ATHEROSCLEROSIS, THROOMBOSES AND / OR Peripheral Vascular Diseases - Google Patents

COMPOSITION FOR TREATMENT OF ATHEROSCLEROSIS, THROOMBOSES AND / OR Peripheral Vascular Diseases

Info

Publication number
DK490486D0
DK490486D0 DK490486A DK490486A DK490486D0 DK 490486 D0 DK490486 D0 DK 490486D0 DK 490486 A DK490486 A DK 490486A DK 490486 A DK490486 A DK 490486A DK 490486 D0 DK490486 D0 DK 490486D0
Authority
DK
Denmark
Prior art keywords
throomboses
atherosclerosis
treatment
composition
peripheral vascular
Prior art date
Application number
DK490486A
Other languages
Danish (da)
Other versions
DK490486A (en
Inventor
Bernward Schoelkens
Original Assignee
Hoechst Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoechst Ag filed Critical Hoechst Ag
Publication of DK490486D0 publication Critical patent/DK490486D0/en
Publication of DK490486A publication Critical patent/DK490486A/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/04—Linear peptides containing only normal peptide links
    • C07K7/14—Angiotensins: Related peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/55—Protease inhibitors
    • A61K38/556—Angiotensin converting enzyme inhibitors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/08—Vasodilators for multiple indications
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Abstract

The preferred angiotensin converting enzyme inhibitors have the formula I <IMAGE> in which n is 1 or 2, R, R<1>, R<2> and R<3> are identical or different and each is hydrogen or an organic radical, and R<4> and R<5> form, together with the atoms carrying them, a mono-, bi- or tricyclic heterocyclic ring system. Agents containing these compounds for treating the specified diseases are also described.
DK490486A 1985-10-15 1986-10-14 COMPOSITION FOR TREATMENT OF ATHEROSCLEROSIS, THROOMBOSES AND / OR Peripheral Vascular Diseases DK490486A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE19853536687 DE3536687A1 (en) 1985-10-15 1985-10-15 METHOD FOR TREATING ATHEROSCLEROSIS, THROMBOSIS AND PERIPHERAL VESSEL DISEASE

Publications (2)

Publication Number Publication Date
DK490486D0 true DK490486D0 (en) 1986-10-14
DK490486A DK490486A (en) 1987-04-16

Family

ID=6283587

Family Applications (1)

Application Number Title Priority Date Filing Date
DK490486A DK490486A (en) 1985-10-15 1986-10-14 COMPOSITION FOR TREATMENT OF ATHEROSCLEROSIS, THROOMBOSES AND / OR Peripheral Vascular Diseases

Country Status (12)

Country Link
EP (1) EP0219782B1 (en)
JP (1) JPS6287524A (en)
KR (1) KR930008094B1 (en)
AT (1) ATE95064T1 (en)
AU (1) AU594711B2 (en)
CA (1) CA1320904C (en)
DE (2) DE3536687A1 (en)
DK (1) DK490486A (en)
ES (1) ES2059301T3 (en)
IE (1) IE60767B1 (en)
PT (1) PT83535B (en)
ZA (1) ZA867771B (en)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4962105A (en) 1987-10-19 1990-10-09 Ciba-Geigy Corporation Potentiation of antihypertensive effect of ace inhibitors
DE3818245A1 (en) * 1988-05-28 1989-12-07 Hoechst Ag COMBINATION OF ANGIOTENSIN CONVERTING ENZYME INHIBITORS WITH COLD CHANNEL MODULATORS AND THEIR USE IN MEDICINAL PRODUCTS
US4931464A (en) * 1989-02-15 1990-06-05 E. R. Squibb & Sons, Inc. Method of reducing pre- and post-ischemic myocardial arrhythmias and fibrillation
CA2016467A1 (en) 1989-06-05 1990-12-05 Martin Eisman Method for treating peripheral atherosclerotic disease employing an hmg coa reductase inhibitor and/or a squalene synthetase inhibitor
DE3923402A1 (en) * 1989-07-14 1991-01-17 Thera Patent Verwaltungs Gmbh USE OF ACE INHIBITORS FOR THE PROPHYLAXIS AND THERAPY OF THE CHRONIC-VENOESE INSUFFICIENCY
DE3925759A1 (en) * 1989-08-03 1991-02-07 Thera Patent Verwaltungs Gmbh USE OF ACE INHIBITORS FOR ATHEROSKLEROSEPROPHYLAXE
US5061694A (en) * 1989-10-23 1991-10-29 E. R. Squibb & Sons, Inc. Method for stabilizing or causing regression of atherosclerosis in coronary arteries employing an ace inhibitor
US5212165A (en) * 1989-10-23 1993-05-18 E. R. Squibb & Sons, Inc. Method for rehabilitating the vasorelaxant action of the coronary arteries impaired through atherosclerosis or hypercholesterolemia employing an ace inhibitor
CA2040865C (en) * 1990-05-15 2002-07-23 James L. Bergey Method for preventing, stabilizing or causing regression of atherosclerosis employing a combination of a cholesterol lowering drug and an ace inhibitor
US5298497A (en) * 1990-05-15 1994-03-29 E. R. Squibb & Sons, Inc. Method for preventing onset of hypertension employing a cholesterol lowering drug
US5140012A (en) * 1990-05-31 1992-08-18 E. R. Squibb & Sons, Inc. Method for preventing onset of restenosis after angioplasty employing pravastatin
US5622985A (en) * 1990-06-11 1997-04-22 Bristol-Myers Squibb Company Method for preventing a second heart attack employing an HMG CoA reductase inhibitor
US5130333A (en) * 1990-10-19 1992-07-14 E. R. Squibb & Sons, Inc. Method for treating type II diabetes employing a cholesterol lowering drug
US5190970A (en) * 1990-10-19 1993-03-02 E. R. Squibb & Sons, Inc. Method for preventing onset of or treating Type II diabetes employing a cholesterol lowering drug alone or in combination with an ace inhibitor
US5157025A (en) * 1991-04-01 1992-10-20 E. R. Squibb & Sons, Inc. Method for lowering serum cholesterol employing a phosphorus containing ace inhibitor alone or in combination with a cholesterol lowering drug
US6369103B1 (en) * 1994-01-18 2002-04-09 Bristol-Myers Squibb Company Method for preventing or reducing risk of onset of cardiovascular events employing an HMG CoA reductase inhibitor
DE69734405T2 (en) * 1996-07-15 2006-08-03 Sankyo Co., Ltd. Use of CS-866 (Olmersartan) for the manufacture of a medicament for the treatment of arteriosclerosis
US6395767B2 (en) 2000-03-10 2002-05-28 Bristol-Myers Squibb Company Cyclopropyl-fused pyrrolidine-based inhibitors of dipeptidyl peptidase IV and method

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4470972A (en) * 1981-04-28 1984-09-11 Schering Corporation 7-Carboxyalkylaminoacyl-1,4-dithia-7-azaspiro[4.4]-nonane-8-carboxylic acids
US4374847A (en) * 1980-10-27 1983-02-22 Ciba-Geigy Corporation 1-Carboxyalkanoylindoline-2-carboxylic acids
SU1327787A3 (en) * 1981-11-05 1987-07-30 Хехст Аг (Фирма) Method of producing cis,endo-2-azabicyclo-(3,3,0)-octane-3-carboxylic acids or acid-additive salts thereof
DE3438545A1 (en) * 1984-10-20 1986-04-24 Merck Patent Gmbh, 6100 Darmstadt PEPTIDE

Also Published As

Publication number Publication date
DE3536687A1 (en) 1987-04-16
IE862711L (en) 1987-04-15
EP0219782B1 (en) 1993-09-29
DE3689099D1 (en) 1993-11-04
PT83535A (en) 1986-11-01
EP0219782A2 (en) 1987-04-29
DK490486A (en) 1987-04-16
ES2059301T3 (en) 1994-11-16
ATE95064T1 (en) 1993-10-15
KR870004054A (en) 1987-05-07
ZA867771B (en) 1987-05-27
AU6389086A (en) 1987-04-16
IE60767B1 (en) 1994-08-10
CA1320904C (en) 1993-08-03
EP0219782A3 (en) 1990-05-30
JPS6287524A (en) 1987-04-22
AU594711B2 (en) 1990-03-15
KR930008094B1 (en) 1993-08-25
PT83535B (en) 1989-05-31

Similar Documents

Publication Publication Date Title
DK490486D0 (en) COMPOSITION FOR TREATMENT OF ATHEROSCLEROSIS, THROOMBOSES AND / OR Peripheral Vascular Diseases
NO304372B1 (en) Double acting inhibitors and pharmaceutical mixtures containing these
ATE50763T1 (en) TETRALIN DERIVATIVES, THEIR PREPARATION AND USE.
DK104292A (en) HETEROCYCLIC COMPOUNDS AND PROCEDURES FOR THEIR PREPARATION
DE68922044T2 (en) 2,4-diamino-pyrimidine-3-oxide derivatives and their use in the treatment and prevention of hair fall.
DK283881A (en) PROCEDURE FOR PREPARING PYRAZINYL1,2,4-OXADIAZOL-5-ONER
FI840463A0 (en) VISSA BENSAZOKINON- OCH BENSAZONINONDERIVAT
DK0417473T3 (en) Method of treatment of cardiac as well as vascular hypertrophy and hyperplasia
DK609089A (en) PROCEDURE AND MATERIALS FOR MICROBIOLOGICAL CONVERSION OF TOLUEN AND OTHER PHENYL COMPOUNDS
ATE124681T1 (en) MEDICINAL COMPOSITIONS FOR THE TREATMENT OF PSORIASIS.
SE8500107D0 (en) NEW 8ALFA-ACYLAMINOERGOLINE
ES2103104T3 (en) NEW DI- AND POLYAMINIC COMPOUNDS USEFUL IN THE PREPARATION OF POLYURETHANES.
NO177461C (en) Triodobenzene compounds and contrast agents containing these
DE3689853D1 (en) Use of gyrase inhibitors for the decontamination of Mycoplasma-infected cell cultures.
DK149590C (en) METHOD OF ANALOGUE FOR THE PREPARATION OF 2-ARYL-3,4-DIAZA-BICYCLO (4,1,0) HEPTEN- (2) -ON- (5) COMPOUNDS
DK0736009T3 (en) N-oxides of 4-arylpiperazines and 4-arylpiperidines as antipsychotic drugs
EP0297816A3 (en) Homocyclostatine and cyclostatine containing polypeptides as antihypertensive agents
NO305556B1 (en) Thiocarbamoyl compounds and their use as well as means for protecting technical materials
DK528485A (en) PROCEDURE FOR OXYDATION OF OXIDIZABLE ORGANIC COMPOUNDS
DE3664044D1 (en) N, N-DIALKYLAMINOALKYL-HEXAHYDRO-5-OXO-1H-PYRROLIZINE-3-CARBOXAMIDES

Legal Events

Date Code Title Description
ATS Application withdrawn